SSRI Use Resolves Depression, Increases Recurrent Stroke Risk After ICH
SSRI use after intracerebral hemorrhage may resolve depression symptoms, but also increases patients’ risk for recurrent stroke.
All articles by Heather Johnson
People With Depression at Increased Risk of Cannabis Use
The use of cannabis in the past month among US adults with depression increased from 2005 to 2016.
Nighttime Device Use Associated With Insomnia in Young Adults
In young adults, the use of electronic devices was found to contribute to insomnia symptoms more than mood disturbance, age, and biological sex.
Genomic Data May Unlock Clues to Prevent Depression
Using phenotypic and genomic data from more than 100,000 participants, researchers systematically screened and validated a wide range of potential modifiable factors for depression.
Machine Learning May Improve Diagnostic Accuracy in Schizophrenia, Autism Spectrum Disorder
A recent study aimed to assess the ability of classifiers to identify individuals with schizophrenia, autism spectrum disorder, and typical development based on findings from magnetic resonance imaging.
Olanzapine Plus Samidorphan for Schizophrenia Associated With Less Weight Gain
In a phase 3, double-blind trial, the effect of combined olanzapine and samidorphan treatment compared with treatment with olanzapine alone on the weight profile of patients with schizophrenia was evaluated.
Yoga Helps Generalized Anxiety Disorder but Not as Much as CBT
A new randomized controlled clinical trial evaluated whether yoga and cognitive behavioral therapy are each more effective than stress education to treat generalized anxiety disorder.
Study Finds Association Between Sleep Disorders and Anxiety
Among participants living in a culturally diverse area of Greece, people with anxiety were more likely to experience loss of sleep or other sleep-related disorders.
Evaluating the Role of Genetics in Pediatric Suicidal Ideation and Aggression
The use of genetic evaluation for suicidal ideation may represent a future application for precision medicine.
The Lancet Commission Identifies Additional Dementia Risk Factors
The Lancet Commission added 3 new risk factors for dementia that coupled with the previous 9 lifestyle risk factors might prevent or delay up to 40% of dementias worldwide.
-
Loading...
-
Loading...
Next post in Neurocognitive Disorders
